Pharma BD Deal Intelligence

Novo Nordisk A/S / Anthropic PBC

2026 · Co-Development · Complete

Novo Nordisk and Anthropic announced a collaboration under which Novo Nordisk will apply Anthropic's Claude models, including Claude Science, to drug discovery and development workflows and to AI-driven software engineering across the company. The partners said they will jointly target specific scientific challenges and workflows identified by Novo Nordisk's research and computational teams, with stated emphasis on data governance and human oversight. No financial terms were disclosed. NOTE: ingested at pending_review pending pipeline-asset and financial-term enrichment.

This deal is too recent to grade. Critic Score and Outcome Score are assigned after the announcement-week coverage settles and, for Outcome, after the 5-year post-close assessment window opens — expected 2031 at the earliest for this deal, once/if it closes.

Key facts

Related deals

See the full interactive analysis, sources & comparables →

← Browse all deals  ·  How we score deals

More: 2026 deals  ·  Novo Nordisk A/S deals